Pulse Biosciences, Inc. (PLSE)
NCM · Medical Instruments & Supplies
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Peers in Medical Instruments & Supplies
All in industry →Intuitive Surgical, Inc.
Medline Inc.
Becton, Dickinson and Company
Alcon Inc.
ResMed Inc.
West Pharmaceutical Services, Inc.
The Cooper Companies, Inc.
Align Technology, Inc.
Solventum Corporation
Baxter International Inc.
Recent press releases
Pulse Biosciences, Inc. has not issued a press release in this window.
SEC filings
All filings →Pulse Biosciences, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Pulse Biosciences, Inc. has no reported insider trades in the last 90 days.